APA

Eyüpoglu I. Y., Hahnen E., Tränkle C., Savaskan N. E., Siebzehnrübl F. A., Buslei R., Lemke D., Wick W., Fahlbusch R. & Blümcke I. (20060814). Experimental therapy of malignant gliomas using the inhibitor of histone deacetylase MS-275. : Molecular cancer therapeutics.

Chicago

Eyüpoglu Ilker Y, Hahnen Eric, Tränkle Christian, Savaskan Nicolai E, Siebzehnrübl Florian A, Buslei Rolf, Lemke Dieter, Wick Wolfgang, Fahlbusch Rudolf and Blümcke Ingmar. 20060814. Experimental therapy of malignant gliomas using the inhibitor of histone deacetylase MS-275. : Molecular cancer therapeutics.

Harvard

Eyüpoglu I. Y., Hahnen E., Tränkle C., Savaskan N. E., Siebzehnrübl F. A., Buslei R., Lemke D., Wick W., Fahlbusch R. and Blümcke I. (20060814). Experimental therapy of malignant gliomas using the inhibitor of histone deacetylase MS-275. : Molecular cancer therapeutics.

MLA

Eyüpoglu Ilker Y, Hahnen Eric, Tränkle Christian, Savaskan Nicolai E, Siebzehnrübl Florian A, Buslei Rolf, Lemke Dieter, Wick Wolfgang, Fahlbusch Rudolf and Blümcke Ingmar. Experimental therapy of malignant gliomas using the inhibitor of histone deacetylase MS-275. : Molecular cancer therapeutics. 20060814.